iTeos Therapeutics, Inc.
ITOSDelisted Aug 29, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001808865
iTeos Therapeutics, Inc. was delisted on Aug 29, 2025; its insiders filed their last Form 4 on Aug 29, 2025; 137 institutions reported holding it in 13F filings for Q2 2025, worth $377.0M in total; no superinvestor held it.
13F holders, Q1 2025
Institutional positions in iTeos Therapeutics, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 132
- −4 vs. Q4 2024
- Shares held
- 37.0M
- +2.89M (+8.5%) vs. Q4 2024
- Total value
- $220.7M
- −$41.0M (−15.7%) vs. Q4 2024
- New holders
- 20
- 42 more added
- Sold out
- 24
- 44 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ITOS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 1 | $2.35K |
| Q2 2025 | 137 | $377.0M |
| Q1 2025 | 132 | $220.7M |
| Q4 2024 | 137 | $262.2M |
| Q3 2024 | 151 | $373.3M |
| Q2 2024 | 139 | $536.8M |
| Q1 2024 | 136 | $471.2M |
| Q4 2023 | 138 | $383.4M |
| Q3 2023 | 144 | $388.6M |
| Q2 2023 | 146 | $460.4M |
| Q1 2023 | 153 | $488.9M |
| Q4 2022 | 146 | $707.3M |
| Q3 2022 | 143 | $698.2M |
| Q2 2022 | 153 | $768.1M |
| Q1 2022 | 159 | $1.17B |
| Q4 2021 | 118 | $1.55B |
| Q3 2021 | 77 | $841.3M |
| Q2 2021 | 83 | $755.8M |
| Q1 2021 | 81 | $1.03B |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding iTeos Therapeutics, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caption Management, LLC | 154,493 | $922.3K | 0.04% | −355,336−69.7% | Reduced |
| Kennedy Capital Management, Inc. | 154,717 | $923.7K | 0.02% | +16,126+11.6% | Added |
| Bank of America Corp | 180,104 | $1.08M | 0.00% | +118,773+193.7% | Added |
| Trexquant Investment LP | 188,500 | $1.13M | 0.01% | +8,534+4.7% | Added |
| Ameriprise Financial Inc | 197,902 | $1.18M | 0.00% | −7,286−3.6% | Reduced |
| DAFNA Capital Management LLC | 213,347 | $1.27M | 0.36% | +25,000+13.3% | Added |
| Eversept Partners, LP | 220,196 | $1.31M | 0.15% | 00.0% | Unchanged |
| AQR Capital Management LLC | 226,210 | $1.35M | 0.00% | +106,260+88.6% | Added |
| Charles Schwab Investment Management Inc | 233,561 | $1.39M | 0.00% | +34,365+17.3% | Added |
| Northern Trust Corp | 250,125 | $1.49M | 0.00% | −9,612−3.7% | Reduced |
| Morgan Stanley | 251,131 | $1.50M | 0.00% | +514+0.2% | Added |
| Almitas Capital LLC | 275,120 | $1.64M | 0.54% | 00.0% | Unchanged |
| Nuveen, LLC | 303,650 | $1.81M | 0.00% | +303,650 | New |
| Millennium Management LLC | 348,359 | $2.08M | 0.00% | −62,713−15.3% | Reduced |
| Acadian Asset Management LLC | 536,787 | $3.20M | 0.01% | +66,641+14.2% | Added |
| Jacobs Levy Equity Management, Inc | 557,936 | $3.33M | 0.01% | −364,198−39.5% | Reduced |
| State Street Corp | 581,997 | $3.47M | 0.00% | −3,939−0.7% | Reduced |
| Goldman Sachs Group Inc | 587,420 | $3.51M | 0.00% | −143,071−19.6% | Reduced |
| Renaissance Technologies LLC | 645,600 | $3.85M | 0.01% | −191,600−22.9% | Reduced |
| Geode Capital Management, LLC | 650,053 | $3.88M | 0.00% | +5,152+0.8% | Added |
| Vestal Point Capital, LP | 900,000 | $5.37M | 0.38% | 00.0% | Unchanged |
| Citadel Advisors LLC | 1,179,722 | $7.04M | 0.01% | −252,540−17.6% | Reduced |
| Dimensional Fund Advisors LP | 1,181,254 | $7.05M | 0.00% | −28,826−2.4% | Reduced |
| Vanguard Group Inc | 1,726,458 | $10.3M | 0.00% | +92,429+5.7% | Added |
| MPM Oncology Impact Management LP | 1,745,943 | $10.4M | 1.79% | 00.0% | Unchanged |
| 683 Capital Management, LLC | 1,750,000 | $10.4M | 1.06% | +831,883+90.6% | Added |
| JPMorgan Chase & Co | 1,982,663 | $11.8M | 0.00% | −86,133−4.2% | Reduced |
| Tang Capital Management LLC | 2,689,200 | $16.1M | 0.89% | +2,467,484+1,112.9% | Added |
| MPM Asset Management LLC | 2,738,785 | $16.4M | 23.55% | 00.0% | Unchanged |
| BVF Inc | 3,075,000 | $18.4M | 0.75% | +750,000+32.3% | Added |
| Ra Capital Management, L.P. | 3,649,057 | $21.8M | 0.36% | +1,556,798+74.4% | Added |
| BlackRock, Inc. | 4,509,247 | $26.9M | 0.00% | +707,738+18.6% | Added |
| Boxer Capital Management, LLC | 0 | $0 | 0.00% | −946,915−100.0% | Sold out |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −150,967−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −125,589−100.0% | Sold out |
| Empowered Funds, LLC | 0 | $0 | 0.00% | −69,072−100.0% | Sold out |
| Squarepoint Ops LLC | 0 | $0 | 0.00% | −42,716−100.0% | Sold out |
| Fox Run Management, L.L.C. | 0 | $0 | 0.00% | −37,838−100.0% | Sold out |
| EntryPoint Capital, LLC | 0 | $0 | 0.00% | −29,850−100.0% | Sold out |
| Balyasny Asset Management LLC | 0 | $0 | 0.00% | −28,350−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −27,352−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −24,964−100.0% | Sold out |
| LMR Partners LLP | 0 | $0 | 0.00% | −22,972−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −18,493−100.0% | Sold out |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −15,866−100.0% | Sold out |
| Jain Global LLC | 0 | $0 | 0.00% | −13,800−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −8,948−100.0% | Sold out |
| Point72 (DIFC) Ltd | 0 | $0 | 0.00% | −8,794−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −6,070−100.0% | Sold out |
| Zurcher Kantonalbank (Zurich Cantonalbank) | 0 | $0 | 0.00% | −2,574−100.0% | Sold out |
| Leonteq Securities AG | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −1,237−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −533−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −172−100.0% | Sold out |
| Quadrant Capital Group LLC | 0 | $0 | 0.00% | −135−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −19−100.0% | Sold out |
| Nuveen Asset Management, LLC | – | – | – | – | Not filed |